Clinical Trial Update: Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update reports the completion of a Phase 2 trial evaluating Zactima (vandetanib) in elderly patients with non-small cell lung cancer, in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Zactima (vandetanib)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-09-28